Akumin Inc. (AKU): Price and Financial Metrics


Akumin Inc. (AKU): $3.12

-0.03 (-0.95%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

AKU Stock Price Chart Interactive Chart >

Price chart for AKU

AKU Price/Volume Stats

Current price $3.12 52-week high $4.10
Prev. close $3.15 52-week low $1.69
Day low $3.07 Volume 15,800
Day high $3.16 Avg. volume 123,599
50-day MA $3.02 Dividend yield N/A
200-day MA $3.24 Market Cap 222.00M

Akumin Inc. (AKU) Company Bio


Akumin Inc. provides outpatient diagnostic imaging services in the United States. As of December 31, 2019, the company operated 129 imaging centers located in Florida, Pennsylvania, Delaware, Georgia, Texas, Illinois, and Kansas. Its centers offer physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders, and reduce unnecessary invasive procedures. The company provides a range of medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, digital radiography, fluoroscopy, radiology, and other diagnostic or interventional radiology procedures; and online medical bill payment services. Akumin Inc. is headquartered in Toronto, Canada.


AKU Latest News Stream


Event/Time News Detail
Loading, please wait...

AKU Latest Social Stream


Loading social stream, please wait...

View Full AKU Social Stream

Latest AKU News From Around the Web

Below are the latest news stories about Akumin Inc that investors may wish to consider to help them evaluate AKU as an investment opportunity.

Akumin Provides Updates Related to Alliance HealthCare Services Acquisition

Akumin Inc. (NASDAQ: AKU) (TSX: AKU) ("Akumin") is pleased to provide an update with respect to its previously announced proposed acquisition of Alliance HealthCare Services, Inc. ("Alliance") and to announce the filing today in Akumin's public disclosure at www.sedar.com and www.sec.gov of (i) consolidated financial statements of Alliance for the years ended December 31, 2020 and 2019, (ii) condensed consolidated financial statements of Alliance as of March 31, 2021, (iii) unaudited pro forma c

Yahoo | July 26, 2021

Akumin Inc. Announces Proposed Offering of Senior Secured Notes

Akumin Inc. (NASDAQ: AKU) (TSX: AKU) (the "Issuer" or "Akumin") announced today that Akumin Escrow Inc. (the "Escrow Issuer"), a wholly owned subsidiary of the Issuer that is to be liquidated into the Issuer, plans to offer, subject to market and other conditions, senior secured notes in a private offering (the "Private Offering") that is exempt from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act").

Yahoo | July 26, 2021

Akumin to Snap up Alliance HealthCare Services; Street Sees 39% Upside

Akumin (AKU) has agreed to acquire Alliance HealthCare Services at an enterprise valuation of $820 million. The transaction is expected to close in Q3. Akumin provides freestanding outpatient radiology services. Alliance provides radiology and oncology solutions to hospitals, health systems, as well as physician groups. The move is expected to create comprehensive radiology and oncology solutions providers in the U.S. with pro forma revenues of over $730 million. Akumin President and CEO Riadh Zine said, “The acquisition of Alliance is transformative in a changing healthcare ecosystem that continues to shift toward outpatient, price-transparent, value-based care.

Kailas Salunkhe on TipRanks | June 28, 2021

Akumin Inc. -- Moody''s places Akumin''s ratings under review for downgrade following Alliance acquisition announcement

Rating Action: Moody''s places Akumin''s ratings under review for downgrade following Alliance acquisition announcement Read the full article at Moody''s

Business Insider Markets | June 28, 2021

Akumin To Acquire Alliance HealthCare Services With An Enterprise Value Of $820M

Akumin Inc (NASDAQ: AKU ) has agreed to acquire Alliance HealthCare Services Inc , a provider of radiology and oncology solutions to hospitals, health systems, and physician groups. The transaction has an enterprise value of $820 million and is expected to close in the third quarter of 2021. The combined company is expected to have pro forma revenue over $730 million and pro forma Full story available on Benzinga.com

Benzinga | June 25, 2021

Read More 'AKU' Stories Here

AKU Price Returns

1-mo -4.00%
3-mo 0.97%
6-mo -0.95%
1-year 80.35%
3-year N/A
5-year N/A
YTD 3.65%
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7461 seconds.